(19)

(11)

EP 4 562 636 A1

(12)

(43) Date of publication: 04.06.2025 Bulletin 2025/23 (21) Application number: 23847485.2 (22) Date of filing: 24.07.2023

(51) International Patent Classification (IPC):  G16B 20/10(2019.01) G16B 35/20(2019.01) G16H 50/20(2018.01) G16B 20/20(2019.01) C12Q 1/6869(2018.01) (52) Cooperative Patent Classification (CPC): G16H 50/20; G16B 35/20; G16B 20/10; G16B 20/20; G16H 10/40; G16H 50/70; G16H 40/67; G16H 20/10; G16H 15/00; G16H 10/60; G16H 50/30 (86) International application number: PCT/US2023/070866 (87) International publication number: WO 2024/026275 (01.02.2024 Gazette 2024/05)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: KH MA MD TN (30) Priority: 29.07.2022 US 202263393487 P 12.08.2022 US 202263397718 P (71) Applicant: Foundation Medicine, Inc. Boston, MA 02210 (US)	(72) Inventor: MONTESION, Meagan Kathleen Boston, Massachusetts 02210 (US) (74) Representative: CMS Cameron McKenna Nabarro Olswang LLP  Cannon Place 78 Cannon Street London EC4N 6AF London EC4N 6AF (GB)